{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:37:05Z","timestamp":1790761025057,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T00:00:00Z","timestamp":1537228800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"This project has received public funding from FIMARAD"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13023-018-0894-3","type":"journal-article","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T08:08:39Z","timestamp":1537258119000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Burden of albinism: development and validation of a burden assessment tool"],"prefix":"10.1186","volume":"13","author":[{"name":"Fili\u00e8re Maladies Rares en Dermatologie: FIMARAD","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Morice-Picard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5142-2479","authenticated-orcid":false,"given":"Charles","family":"Ta\u00efeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelie","family":"Marti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Gliksohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Bennani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bodemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Ezzedine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,18]]},"reference":[{"issue":"3","key":"894_CR1","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1167\/iovs.10-6091","volume":"52","author":"A Gargiulo","year":"2011","unstructured":"Gargiulo A, Testa F, Rossi S, Di Iorio V, Fecarotta S, de Berardinis T, et al. Molecular and clinical characterization of albinism in a large cohort of Italian patients. Invest Ophthalmol Vis Sci. 2011;52(3):1281\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"894_CR2","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1167\/iovs.08-2639","volume":"50","author":"K Gr\u00f8nskov","year":"2009","unstructured":"Gr\u00f8nskov K, Ek J, Sand A, Scheller R, Bygum A, Brixen K, et al. Birth prevalence and mutation spectrum in danish patients with autosomal recessive albinism. Invest Ophthalmol Vis Sci. 2009;50(3):1058\u201364.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"894_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1750-1172-2-43","volume":"2","author":"K Gr\u00f8nskov","year":"2007","unstructured":"Gr\u00f8nskov K, Ek J, Brondum-Nielsen K. Oculocutaneous albinism. Orphanet J Rare Dis. 2007;2:43.","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"894_CR4","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1038\/jid.2008.109","volume":"128","author":"SM Hutton","year":"2008","unstructured":"Hutton SM, Spritz RA. Comprehensive analysis of oculocutaneous albinism among non-Hispanic caucasians shows that OCA1 is the most prevalent OCA type. J Investig Dermatol. 2008;128(10):2442\u201350.","journal-title":"J Investig Dermatol"},{"issue":"2","key":"894_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/(SICI)1098-1004(1999)13:2<99::AID-HUMU2>3.0.CO;2-C","volume":"13","author":"WS Oetting","year":"1999","unstructured":"Oetting WS, King RA. Molecular basis of albinism: mutations and polymorphisms of pigmentation genes associated with albinism. Hum Mutat. 1999;13(2):99\u2013115.","journal-title":"Hum Mutat"},{"issue":"2","key":"894_CR6","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/humu.10311","volume":"23","author":"U Rundshagen","year":"2004","unstructured":"Rundshagen U, Z\u00fchlke C, Opitz S, Schwinger E, K\u00e4smann-Kellner B. Mutations in the MATP gene in five German patients affected by oculocutaneous albinism type 4. Hum Mutat. 2004;23(2):106\u201310.","journal-title":"Hum Mutat"},{"issue":"5","key":"894_CR7","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/j.1755-148X.2008.00496.x","volume":"21","author":"C Rooryck","year":"2008","unstructured":"Rooryck C, Morice-Picard F, El\u00e7ioglu NH, Lacombe D, Taieb A, Arveiler B. Molecular diagnosis of oculocutaneous albinism: new mutations in the OCA1-4 genes and practical aspects. Pigment Cell Melanoma Res. 2008;21(5):583\u20137.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"3","key":"894_CR8","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1086\/382195","volume":"74","author":"K Inagaki","year":"2004","unstructured":"Inagaki K, Suzuki T, Shimizu H, Ishii N, Umezawa Y, Tada J, et al. Oculocutaneous albinism type 4 is one of the most common types of albinism in Japan. Am J Hum Genet. 2004;74(3):466\u201371.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"894_CR9","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/pd.1439","volume":"26","author":"S-Y Lin","year":"2006","unstructured":"Lin S-Y, Chien S-C, Su Y-N, Lee C-N, Chen C-P. Rapid genetic analysis of oculocutaneous albinism (OCA1) using denaturing high performance liquid chromatography (DHPLC) system. Prenat Diagn. 2006;26(5):466\u201370.","journal-title":"Prenat Diagn"},{"issue":"1","key":"894_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jdermsci.2007.12.008","volume":"51","author":"T Suzuki","year":"2008","unstructured":"Suzuki T, Tomita Y. Recent advances in genetic analyses of oculocutaneous albinism types 2 and 4. J Dermatol Sci. 2008;51(1):1\u20139.","journal-title":"J Dermatol Sci"},{"issue":"2","key":"894_CR11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jdermsci.2011.02.009","volume":"62","author":"A Wei","year":"2011","unstructured":"Wei A, Yang X, Lian S, Li W. Implementation of an optimized strategy for genetic testing of the Chinese patients with oculocutaneous albinism. J Dermatol Sci. 2011;62(2):124\u20137.","journal-title":"J Dermatol Sci"},{"issue":"7","key":"894_CR12","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1038\/jid.2013.49","volume":"133","author":"A-H Wei","year":"2013","unstructured":"Wei A-H, Zang D-J, Zhang Z, Liu X-Z, He X, Yang L, et al. Exome sequencing identifies SLC24A5 as a candidate gene for nonsyndromic oculocutaneous albinism. J Investig Dermatol. 2013;133(7):1834\u201340.","journal-title":"J Investig Dermatol"},{"issue":"6","key":"894_CR13","first-page":"1320","volume":"56","author":"RA Spritz","year":"1995","unstructured":"Spritz RA, Fukai K, Holmes SA, Luande J. Frequent intragenic deletion of the P gene in Tanzanian patients with type II oculocutaneous albinism (OCA2). Am J Hum Genet. 1995;56(6):1320\u20133.","journal-title":"Am J Hum Genet"},{"issue":"9","key":"894_CR14","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s10038-007-0181-y","volume":"52","author":"R Aquaron","year":"2007","unstructured":"Aquaron R, Soufir N, Berg\u00e9-Lefranc J-L, Badens C, Austerlitz F, Grandchamp B. Oculocutaneous albinism type 2 (OCA2) with homozygous 2.7-kb deletion of the P gene and sickle cell disease in a Cameroonian family. Identification of a common TAG haplotype in the mutated P gene. J Hum Genet. 2007;52(9):771\u201380.","journal-title":"J Hum Genet"},{"issue":"1","key":"894_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.det.2010.08.015","volume":"29","author":"AE Cruz-Inigo","year":"2011","unstructured":"Cruz-Inigo AE, Ladizinski B, Sethi A. Albinism in Africa: stigma, slaughter and awareness campaigns. Dermatol Clin. 2011;29(1):79\u201387.","journal-title":"Dermatol Clin"},{"issue":"3","key":"894_CR16","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ajhg.2013.01.006","volume":"92","author":"K Gr\u00f8nskov","year":"2013","unstructured":"Gr\u00f8nskov K, Dooley CM, \u00d8stergaard E, Kelsh RN, Hansen L, Levesque MP, et al. Mutations in c10orf11, a melanocyte-differentiation gene, cause autosomal-recessive albinism. Am J Hum Genet. 2013;92(3):415\u201321.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"894_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/1346-8138.12170","volume":"40","author":"M M\u00e1rtinez-Garc\u00eda","year":"2013","unstructured":"M\u00e1rtinez-Garc\u00eda M, Montoliu L. Albinism in Europe. J Dermatol. 2013;40(5):319\u201324.","journal-title":"J Dermatol"},{"issue":"2","key":"894_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jaapos.2008.10.008","volume":"13","author":"BR Kutzbach","year":"2009","unstructured":"Kutzbach BR, Merrill KS, Hogue KM, Downes SJ, Holleschau AM, MacDonald JT, Summers CG. Evaluation of vision-specific quality-of-life in albinism. J AAPOS. 2009;13(2):191\u20135.","journal-title":"J AAPOS"},{"key":"894_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1087-0024.2004.09119.x","volume":"9","author":"MM Chren","year":"2004","unstructured":"Chren MM, Weinstock MA. Conceptual issues in measuring the burden of skin diseases. J Investig Dermatol Symp Proc. 2004;9:97\u2013100.","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"6","key":"894_CR20","first-page":"693","volume":"150","author":"RJ Hay","year":"2015","unstructured":"Hay RJ, Fuller LC. Global burden of skin disease in the elderly: a grand challenge to skin health. G Ital Dermatol Venereol. 2015;150(6):693\u20138.","journal-title":"G Ital Dermatol Venereol"},{"issue":"1","key":"894_CR21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.2340\/00015555-1847","volume":"95","author":"O Boccara","year":"2015","unstructured":"Boccara O, M\u00e9ni C, L\u00e9aut\u00e9-Labreze C, Bodemer C, Voisard J-J, Dufresne H, et al. Haemangioma family burden: creation of a specific questionnaire. Acta Derm Venereol. 2015;95(1):78\u201382.","journal-title":"Acta Derm Venereol"},{"key":"894_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1750-1172-8-28","volume":"8","author":"H Dufresne","year":"2013","unstructured":"Dufresne H, Hadj-Rabia S, M\u00e9ni C, Sibaud V, Bodemer C, Ta\u00efeb C. Family burden in inherited ichthyosis: creation of a specific questionnaire. Orphanet J Rare Dis. 2013;8:28.","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"894_CR23","doi-asserted-by":"publisher","first-page":"700","DOI":"10.2340\/00015555-1945","volume":"95","author":"A Ta\u00efeb","year":"2015","unstructured":"Ta\u00efeb A, Boralevi F, Seneschal J, Merhand S, Georgescu V, Taieb C, et al. Atopic dermatitis burden scale for adults: development and validation of a new assessment tool. Acta Derm Venereol. 2015;95(6):700\u20135.","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"894_CR24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/JID.2015.398","volume":"136","author":"C Salzes","year":"2016","unstructured":"Salzes C, Abadie S, Seneschal J, Whitton M, Meurant J-M, Jouary T, et al. The vitiligo impact patient scale (VIPs): development and validation of a vitiligo burden assessment tool. J Invest Dermatol. 2016;136(1):52\u20138.","journal-title":"J Invest Dermatol"},{"key":"894_CR25","unstructured":"Marquis P. Development and validation of a questionnaire: state of the art and level of evidence requiered. In: Marquis P, editor. Health-Related Quality Of Life And Patient Reported Outcomes: Scientific And Useful Outcome Criteria. London: Springer; 2002. p. 35\u201345."},{"key":"894_CR26","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1524-4733.2007.00292.x","volume":"11","author":"C Acquadro","year":"2008","unstructured":"Acquadro C, Conway K, Hareendran A, Aaronson N. European regulatory issues and quality of life assessment (ERIQA) group. Literature review of methods to translate health-related quality of life questionnaires for use in multinational clinical trials. Value Health. 2008;11:509\u201321.","journal-title":"Value Health"},{"key":"894_CR27","first-page":"37","volume-title":"Quality of life assessments in clinical trials","author":"G Guyatt","year":"1990","unstructured":"Guyatt G, Jaeschke R. Measurements in clinical trials: choosing the appropriate approach. In: Spilker B, editor. Quality of life assessments in clinical trials. New York: Raven Press; 1990. p. 37\u201346."},{"key":"894_CR28","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/BF02289113","volume":"6","author":"LJ Cronbach","year":"1951","unstructured":"Cronbach LJ, Warrington WG. Time-limit tests: estimating their reliability and degree of speeding. Psychometrika. 1951;6:167\u201388.","journal-title":"Psychometrika"},{"key":"894_CR29","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1037\/0033-2909.107.2.238","volume":"107","author":"PM Bentler","year":"1990","unstructured":"Bentler PM. Comparative fit indexes in structural models. Psychol Bull. 1990;107:238\u201346.","journal-title":"Psychol Bull"},{"key":"894_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/A:1026409226544","volume":"8","author":"LL Lim","year":"1999","unstructured":"Lim LL, Fisher JD. Use of the 12-item short-form (SF-12) Health Survey in an Australian heart and stroke population. Qual Life Res. 1999;8:1\u20138.","journal-title":"Qual Life Res"},{"key":"894_CR31","volume-title":"Society and the Adolescent Self-Image","author":"M Rosenberg","year":"1989","unstructured":"Rosenberg M. Society and the Adolescent Self-Image. Rev ed. Middletown: Wesleyan University Press; 1989.","edition":"Rev"},{"key":"894_CR32","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","volume":"19","author":"AY Finlay","year":"1994","unstructured":"Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210\u20136.","journal-title":"Clin Exp Dermatol"},{"key":"894_CR33","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1087-0024.2004.09113.x","volume":"9","author":"V Lewis","year":"2004","unstructured":"Lewis V, Finlay AY. 10 years experience of the dermatology life questionnaire. J Investig Dermatol Symp Proc. 2004;9:169\u201380.","journal-title":"J Investig Dermatol Symp Proc"},{"key":"894_CR34","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1524-4733.2005.04054.x","volume":"8","author":"D Wild","year":"2005","unstructured":"Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, Erikson P, ISPOR Task Force for Translation and Cultural Adaptation. Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health. 2005;8:94\u2013104.","journal-title":"Value Health"},{"issue":"4","key":"894_CR35","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1590\/abd1806-4841.20153498","volume":"90","author":"M Maria","year":"2015","unstructured":"Maria M, Volpini BMF, dos Santos GA, Rujula MJP. Quality of life in patients with oculocutaneous albinism. An Bras Dermatol. 2015;90(4):513\u20137.","journal-title":"An Bras Dermatol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0894-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-018-0894-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0894-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T19:11:20Z","timestamp":1568747480000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-018-0894-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,18]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["894"],"URL":"https:\/\/doi.org\/10.1186\/s13023-018-0894-3","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,18]]},"assertion":[{"value":"12 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"It is in this context that the questionnaire construction project was carried out, the RADICO-FARD project obtained a favorable opinion from the Committee for the Protection of Individuals (CPP Ouest V, Rennes) on July 31, 2017.The questionnaire was proposed by the patient association; at no time did the authors of the project or the persons in charge of the analgesia statistics know the identity of the responders.There was no way to make a connection between the answers obtained and the person who answered the questionnaire.One of our information in order to obtain the respondent\u2019s consent was proposed. This note and consent clearly explained the purpose of the project and guaranteed the anonymity of the responses.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"162"}}